This was a post-hoc analysis of the CAPRIE ( Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events ) trial that compared clopidogrel and aspirin monotherapy in patients ( N = @,@ ) with atherosclerotic vascular disease .